Related Experiment Videos
Structural rearrangements on HIV-1 Tat (32-72) TAR complex formation
A U Metzger1, T Schindler, D Willbold
1Lehrstuhl für Biopolymere, Universität Bayreuth, Germany.
FEBS Letters
|April 22, 1996
Summary
The human immunodeficiency virus type-I (HIV-1) trans-activator (Tat) protein binds to the trans-activation responsive element (TAR) RNA. This binding causes a slight conformational change in TAR RNA, facilitating Tat binding.
Area of Science:
- Molecular Biology
- Virology
- Biochemistry
Background:
- Human immunodeficiency virus type-I (HIV-1) early gene expression is regulated by the trans-activator (Tat) protein.
- Tat protein function depends on binding to the trans-activation responsive element (TAR), an RNA sequence crucial for lentiviral mRNA.
Purpose of the Study:
- To investigate the conformational changes of HIV-1 TAR RNA upon binding to the HIV-1 (32-72) Tat peptide, known as BP1.
- To understand how BP1 facilitates the specific binding to TAR RNA.
Main Methods:
- Spectroscopic methods were employed to analyze the structural interactions.
- The study focused on the conformational dynamics of TAR RNA in complex with the BP1 peptide.
Main Results:
- The binding of BP1 to TAR RNA induces a slight conformational shift from the regular A-form towards the B-form.
- This conformational change results in a widened major groove of the TAR RNA.
- BP1 peptide likely adopts an extended conformation, fitting effectively into the widened major groove.
Conclusions:
- The conformational flexibility of TAR RNA is critical for Tat peptide binding.
- The observed structural changes facilitate the specific and efficient interaction between BP1 and TAR RNA.
- Understanding these molecular interactions provides insights into HIV-1 gene regulation mechanisms.